Earth Science Tech, Inc. (ETST) Poised to Leverage Full-Spectrum CBD Product Line in Projected $2 Billion Market
- Earth Science Tech to add three full-spectrum CBD chocolate offerings to product line
- Testing to begin on CBD-based patent products
- Earth Science Tech products will be available to 90,000 retail outlets throughout U.S.
On the heels of a major decision by the U.S. Food and Drug Administration (FDA) to approve Epidiolex, a drug derived from pure cannabidiol (CBD), to treat seizures associated with certain forms of severe epilepsy, Earth Science Tech, Inc. (OTC: ETST) is repositioning its line of full-spectrum CBD offerings.
Included in this move is the announcement that the company, along with joint venture partner Karmavore Superfoods, will be adding three full-spectrum cannabinoid chocolate products to its CBD line. The options — chocolate-covered mangoes, chocolate coconut peppermint cups and chocolate caramelized quinoa crunch — will contain Earth Science Tech’s high-grade cannabinoid oil and raw arriba nacional cacao, as well as other natural organic superfood ingredients. The chocolates are slated to be available during the third quarter of 2018.
In addition, Earth Science is scheduled to start testing on three new CBD-based patent formulas beginning in late 2018 and extending into 2019. In vitro testing on its first batch of formulas will be aimed at demonstrating the superior antioxidant properties and anti-proliferative effects on breast cancer cells. These compelling products are designed to stop inflammation, maintain quality of life and help prevent cancer and other degenerative diseases.
With these highly anticipated new products on the horizon, Earth Science is also focusing on making its products more available to consumers. The company recently signed agreements with AATAC to offer Earth Science’s CBD products to AATAC’s approximately 90,000 retail outlets throughout the United States. Based on growing consumer interest in CBD and positive response to the announcement, AATAC anticipates a high volume of preorders.
“Our association with AATAC, which is an advisory board that focuses on convenience stores, will give us the opportunity to open up and be available to a market that includes every sector of the population,” Jill Buzan, chief sales officer of ETST, stated in the news release. “This could lead to huge exponential growth for ETST’s sales in the next few months.”
This focus on CBD products is designed to solidify Earth Science’s position as a leader in a burgeoning CDB product markets. In the last three years, the hemp-derived CBD market has grown from $90 million to $190 million, and The Hemp Business Journal projects $2.1 billion in total CBD sales by 2020 (http://nnw.fm/2EqaR). This tremendous increase comes as a result of a growing recognition of CBD’s natural health and wellness properties, increased public acceptance and use of the ingredient and the wider accessibility — both online and in brick-and-mortar retail shops — of CBD products.
In addition to manufacturing, marketing and distributing cannabinoid products to the nutraceutical and pharmaceutical markets, Earth Science conducts R&D for low-cost, non-invasive medical devices.
For more information, visit the company’s website at www.EarthScienceTech.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Earth Science Tech to add three full-spectrum CBD chocolate offerings to product line
- Testing to begin on CBD-based patent products
- Earth Science Tech products will be available to 90,000 retail outlets throughout U.S.
On the heels of a major decision by the U.S. Food and Drug Administration (FDA) to approve Epidiolex, a drug derived from pure cannabidiol (CBD), to treat seizures associated with certain forms of severe epilepsy, Earth Science Tech, Inc. (OTC: ETST) is repositioning its line of full-spectrum CBD offerings.
Included in this move is the announcement that the company, along with joint venture partner Karmavore Superfoods, will be adding three full-spectrum cannabinoid chocolate products to its CBD line. The options — chocolate-covered mangoes, chocolate coconut peppermint cups and chocolate caramelized quinoa crunch — will contain Earth Science Tech’s high-grade cannabinoid oil and raw arriba nacional cacao, as well as other natural organic superfood ingredients. The chocolates are slated to be available during the third quarter of 2018.
In addition, Earth Science is scheduled to start testing on three new CBD-based patent formulas beginning in late 2018 and extending into 2019. In vitro testing on its first batch of formulas will be aimed at demonstrating the superior antioxidant properties and anti-proliferative effects on breast cancer cells. These compelling products are designed to stop inflammation, maintain quality of life and help prevent cancer and other degenerative diseases.
With these highly anticipated new products on the horizon, Earth Science is also focusing on making its products more available to consumers. The company recently signed agreements with AATAC to offer Earth Science’s CBD products to AATAC’s approximately 90,000 retail outlets throughout the United States. Based on growing consumer interest in CBD and positive response to the announcement, AATAC anticipates a high volume of preorders.
“Our association with AATAC, which is an advisory board that focuses on convenience stores, will give us the opportunity to open up and be available to a market that includes every sector of the population,” Jill Buzan, chief sales officer of ETST, stated in the news release. “This could lead to huge exponential growth for ETST’s sales in the next few months.”
This focus on CBD products is designed to solidify Earth Science’s position as a leader in a burgeoning CDB product markets. In the last three years, the hemp-derived CBD market has grown from $90 million to $190 million, and The Hemp Business Journal projects $2.1 billion in total CBD sales by 2020 (http://nnw.fm/2EqaR). This tremendous increase comes as a result of a growing recognition of CBD’s natural health and wellness properties, increased public acceptance and use of the ingredient and the wider accessibility — both online and in brick-and-mortar retail shops — of CBD products.
In addition to manufacturing, marketing and distributing cannabinoid products to the nutraceutical and pharmaceutical markets, Earth Science conducts R&D for low-cost, non-invasive medical devices.
For more information, visit the company’s website at www.EarthScienceTech.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
